MAX CHENG: Open Payments
NPI 1679249320 · JACKSONVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,753 in 35 payments from 10 companies in 2025. Trend: 2023 $948 · 2024 $435 · 2025 $1,753
Food & beverage: $1,753
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 8 | $409 |
| CeQur Corporation | 1 | $329 |
| Xeris Pharmaceuticals, Inc. | 9 | $273 |
| Novo Nordisk Inc | 5 | $197 |
| Amgen Inc. | 1 | $125 |
| Corcept Therapeutics | 1 | $125 |
| Lilly USA, LLC | 5 | $107 |
| BETA BIONICS, INC. | 1 | $84 |
| Dexcom, Inc. | 3 | $80 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
Products named: FREESTYLE LIBRE 3, CeQur Simplicity, GVOKE HYPOPEN, Ozempic, TEPEZZA, Korlym, MOUNJARO, iLet Bionic Pancreas.
Industry payments across FL — which companies pay providers there.
